PerkinElmer EnLite NeoNatal TREC Kit

PerkinElmer announced the commercial availability in the US and Canada of the EnLite Neonatal TREC Kit, a screening test for Severe Combined Immunodeficiency (SCID), also known more commonly as “Bubble Boy” disease. PerkinElmer has received market authorization from the FDA and from Health Canada to offer the test, which provides a semi-quantitative determination of T-cell receptor excision circle (TREC), a circular DNA structure which is the primary identifiable marker for SCID. The test identifies newborns for confirmatory testing which leads to diagnosis.